1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with e 5880 in 19 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (e 5880) | Trials (e 5880) | Recent Studies (post-2010) (e 5880) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 35 | 2 | 8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 10 (52.63) | 18.2507 |
| 2000's | 9 (47.37) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asano, O; Harada, K; Katayama, K; Kimura, A; Kobayashi, S; Murakami, M; Nagaoka, J; Yamada, K; Yamatsu, I; Yoshimura, T | 1 |
| Bel-Haouari, M; Boudjema, K; Chenard, MP; Cinqualbre, J; Doghmi, M; Jaeck, D; Takada, Y; Wolf, P | 1 |
| Boudjema, K; Chenard, MP; Cinqualbre, J; Jaeck, D; Takada, Y; Wolf, P; Yamaoka, Y | 1 |
| Asano, O; Horie, T; Suzuki, H; Tadano, K | 1 |
| Kambayashi, J; Kawasaki, T; Mori, T; Ou, MC; Sakon, M; Shiba, E; Shinozaki, K; Uemura, Y; Yukawa, M | 1 |
| Mochizuki, H; Ono, S; Tamakuma, S | 1 |
| Ando, H; Kobayashi, K; Nakatani, T; Sakamoto, Y | 1 |
| Fukao, K; Fukunaga, K; Iijima, T; Otsuka, M; Takada, Y; Taniguchi, H; Todoroki, T; Yuzawa, K | 1 |
| Fukao, K; Fukunaga, K; Otsuka, M; Takada, Y; Taniguchi, H; Yuzawa, K | 1 |
| Fukao, K; Fukunaga, K; Goto, K; Otsuka, M; Takada, Y; Taniguchi, H | 1 |
| Fukao, K; Fukunaga, K; Gu, M; Ishiguro, S; Otsuka, M; Seino, K; Takada, Y; Taniguchi, H; Yuzawa, K | 1 |
| Asai, Y; Iwamoto, K; Murahashi, N; Nomura, T | 1 |
| Asai, Y; Watanabe, S | 1 |
| Degawa, H; Hama, K; Iwamoto, H; Kikuchi, K; Kozaki, K; Kozaki, M; Matsuno, N; Nagao, T; Narumi, Y; Takeuchi, H; Uchiyama, M | 1 |
| Fukao, K; Fukunaga, K; Gu, M; Ishiguro, S; Otsuka, M; Seino, K; Takada, Y; Taniguchi, H; Todoroki, T; Yuzawa, K | 1 |
| Endo, S; Hirashima, Y; Kobayashi, N; Nukui, H; Takaku, A | 1 |
| Ichinowatari, G; Ohuchi, K; Tanimoto, A; Tsuyuki, K; Yaginuma, H; Yamada, M | 1 |
| Abe, Y; Hori, T; Kasuya, H; Suzuki, S; Yamanishi, Y | 1 |
| Asai, Y | 1 |
2 trial(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and e 5880
| Article | Year |
|---|---|
A clinical study on the significance of platelet-activating factor in the pathophysiology of septic disseminated intravascular coagulation in surgery.
Topics: Carcinoma, Hepatocellular; Data Interpretation, Statistical; Disseminated Intravascular Coagulation; Endotoxins; Gastrointestinal Neoplasms; Humans; Liver Neoplasms; Piperidines; Platelet Activating Factor; Pyridinium Compounds; Sepsis; Surgical Procedures, Operative | 1996 |
Effect of a platelet-activating factor receptor antagonist, E5880, on cerebral vasospasm after aneurysmal subarachnoid hemorrhage--open clinical trial to investigate efficacy and safety.
Topics: Adult; Aged; Aneurysm, Ruptured; Brain; Clinical Protocols; Dose-Response Relationship, Drug; Female; Humans; Incidence; Injections, Intravenous; Intracranial Aneurysm; Male; Middle Aged; Piperidines; Platelet Activating Factor; Platelet Membrane Glycoproteins; Pyridinium Compounds; Radiography; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Subarachnoid Hemorrhage; Treatment Outcome; Vasospasm, Intracranial | 2001 |
17 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and e 5880
| Article | Year |
|---|---|
Inhibitory effects of the novel platelet activating factor receptor antagonist, 1-ethyl-2-[N-(2-methoxy)benzoyl-N-[(2R)-2-methoxy-3-(4- octadecylcarbamoyloxy) piperidinocarbonyloxypropyloxy]carbonyl] aminomethyl-pyridinium chloride, in several experimenta
Topics: Animals; Gas Chromatography-Mass Spectrometry; Hypotension; Lipopolysaccharides; Mice; Mice, Inbred ICR; Passive Cutaneous Anaphylaxis; Piperidines; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Pyridinium Compounds; Rats; Rats, Inbred F344; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Shock | 1991 |
Effects of platelet-activating factor antagonist on preservation/reperfusion injury of the graft in porcine orthotopic liver transplantation.
Topics: Adenosine; Allopurinol; Animals; Glutathione; Graft Rejection; Insulin; Leukocyte Count; Liver; Liver Transplantation; Microscopy, Electron; Mitochondria, Liver; Organ Preservation Solutions; Piperidines; Platelet Activating Factor; Pyridinium Compounds; Raffinose; Reperfusion Injury; Swine; Tissue Preservation; Transaminases | 1995 |
Platelet activating factor antagonist has a protective effect on preservation/reperfusion injury of the graft in pig liver transplantation.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Heparin; Hepatectomy; Ketone Bodies; Lactates; Leukocyte Count; Liver Transplantation; Neutrophils; Organ Preservation; Piperidines; Platelet Activating Factor; Platelet Count; Pyridinium Compounds; Random Allocation; Reperfusion Injury; Swine; Time Factors | 1995 |
Radioimmunoassay for the novel platelet activating factor receptor antagonist E5880.
Topics: Adsorption; Animals; Chromatography, High Pressure Liquid; Dogs; Drug Stability; Immune Sera; Male; Piperidines; Platelet Activating Factor; Platelet Membrane Glycoproteins; Pyridinium Compounds; Rabbits; Radioimmunoassay; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Sensitivity and Specificity; Solutions; Spectrophotometry, Ultraviolet; Water | 1994 |
Potential etiologic role of PAF in two major septic complications; disseminated intravascular coagulation and multiple organ failure.
Topics: Alanine Transaminase; Animals; Bacterial Infections; Blood Cell Count; Blood Urea Nitrogen; Cholangitis; Common Bile Duct; Disseminated Intravascular Coagulation; Endotoxins; Fibrinogen; Hematocrit; Liver; Male; Multiple Organ Failure; Partial Thromboplastin Time; Piperidines; Platelet Activating Factor; Pyridinium Compounds; Rabbits | 1994 |
Effects of platelet-activating factor antagonist E5880 on intrahepatic and systemic metabolic responses to transient hepatic inflow occlusion and reperfusion in the rabbit.
Topics: 6-Ketoprostaglandin F1 alpha; Adenine Nucleotides; Ammonia; Analysis of Variance; Animals; Blood Gas Analysis; Blood Glucose; Energy Metabolism; Hydrogen-Ion Concentration; Lactic Acid; Liver; Male; Piperidines; Platelet Activating Factor; Pyridinium Compounds; Pyruvic Acid; Rabbits; Reperfusion Injury; Thromboxane B2 | 1996 |
Prolonged hepatic warm ischemia in non-heart-beating donors: protective effects of FK506 and a platelet activating factor antagonist in porcine liver transplantation.
Topics: Adenosine Triphosphate; Animals; Aspartate Aminotransferases; Immunosuppressive Agents; Ischemia; Liver; Liver Transplantation; Piperidines; Platelet Activating Factor; Pyridinium Compounds; Swine; Tacrolimus | 1998 |
Energy metabolism of hepatic allografts subjected to prolonged warm ischemia and pharmacologic modulation with FK506 and platelet activating factor antagonist.
Topics: Adenine Nucleotides; Animals; Aspartate Aminotransferases; Energy Metabolism; Graft Survival; Ischemia; Liver; Liver Transplantation; Organ Preservation; Piperidines; Platelet Activating Factor; Postoperative Period; Pyridinium Compounds; Swine; Tacrolimus; Temperature; Transplantation, Homologous | 1998 |
Successful liver transplantation from non-heart-beating donors by blockade of endothelin and PAE.
Topics: Animals; Endothelin Receptor Antagonists; Graft Survival; Heart Arrest, Induced; Liver Transplantation; Peptides, Cyclic; Piperidines; Platelet Activating Factor; Potassium Chloride; Pyridinium Compounds; Swine; Tissue Donors; Transplantation, Homologous | 1998 |
Improvement of allograft viability with organs procured from non-heart-beating donors in porcine liver transplantation.
Topics: Animals; Endothelin-1; Graft Survival; Heart Arrest; Liver Transplantation; Peptides, Cyclic; Piperidines; Platelet Activating Factor; Pyridinium Compounds; Swine; Tacrolimus; Time Factors; Tissue and Organ Harvesting; Transplantation, Homologous | 2000 |
A temperature study on critical micellization concentration of the novel platelet-activating factor receptor antagonist E5880 in water by electric conductivity measurements.
Topics: Drug Administration Routes; Electricity; Micelles; Physical Phenomena; Physics; Piperidines; Platelet Activating Factor; Pyridinium Compounds; Temperature; Water | 2000 |
Characterization of the physicochemical properties of the micelles by the novel platelet activating factor receptor antagonist E5880.
Topics: Algorithms; Chemical Phenomena; Chemistry, Physical; Light; Micelles; Molecular Weight; Particle Size; Piperidines; Platelet Activating Factor; Platelet Membrane Glycoproteins; Pyridinium Compounds; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Scattering, Radiation; Spectrometry, Fluorescence; Surface Properties | 2000 |
Beneficial effect of machine perfusion preservation on liver transplantation from non-heart-beating donors.
Topics: Adenosine; Allopurinol; Animals; Aspartate Aminotransferases; Cold Temperature; Endothelin Receptor Antagonists; Glutathione; Graft Survival; Heart Arrest; Hyaluronic Acid; Insulin; L-Lactate Dehydrogenase; Liver; Liver Transplantation; Organ Preservation; Organ Preservation Solutions; Peptides, Cyclic; Perfusion; Piperidines; Platelet Activating Factor; Pyridinium Compounds; Raffinose; Swine; Transplantation, Homologous | 2000 |
Role of platelet-activating factor in hepatectomy with Pringle's maneuver.
Topics: Adenine Nucleotides; Animals; Blood Pressure; Endothelin-1; Energy Metabolism; Enzymes; Female; Hemostatic Techniques; Hepatectomy; Leukocytes; Liver; Piperidines; Platelet Activating Factor; Portal Vein; Postoperative Period; Pyridinium Compounds; Rabbits; Survival Analysis | 2001 |
Possible participation of intracellular platelet-activating factor in NF-kappaB activation in rat peritoneal macrophages.
Topics: Animals; Azepines; Base Sequence; Cells, Cultured; DNA Primers; Hydrolysis; Imidazoles; Lipopolysaccharides; Macrophages, Peritoneal; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; NF-kappa B; Organophosphorus Compounds; Phosphorylation; Piperidines; Platelet Activating Factor; Pyridinium Compounds; Rats; Rats, Sprague-Dawley; Thapsigargin; Triazoles | 2002 |
Effect of a platelet-activating factor antagonist, E5880, on cerebrovasospasm following subarachnoid hemorrhage in a canine double-hemorrhage model.
Topics: Animals; Basilar Artery; Cerebrovascular Circulation; Disease Models, Animal; Dogs; Female; Male; Piperidines; Platelet Activating Factor; Pyridinium Compounds; Subarachnoid Hemorrhage; Time Factors; Vasoconstriction; Vasospasm, Intracranial | 2002 |
Formation of spherical micelles composed of the novel platelet activating factor receptor antagonist, E5880.
Topics: Algorithms; Chemical Phenomena; Chemistry, Pharmaceutical; Chemistry, Physical; Lipids; Micelles; Particle Size; Piperidines; Platelet Activating Factor; Pyridinium Compounds; Surface Properties | 2005 |